Two-step delivery of retroviruses to postmitotic, terminally differentiated cells

Human Gene Therapy

Volumn 8, Issue 1, 1997, Pages 57-63

  Ito, Masamichi ^a,b   Kedes, Larry ^a,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c Institute for Genetic Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; VIRUS LARGE T ANTIGEN;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA INTEGRATION; DNA SYNTHESIS; EXPRESSION VECTOR; GENE EXPRESSION; GENETIC TRANSDUCTION; HISTOCHEMISTRY; MITOSIS; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; MYOBLAST; MYOTUBE; NONHUMAN; RETROVIRUS; SIMIAN VIRUS 40; VIRUS RECOMBINANT;

EID: 0031017660     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.1-57     Document Type: Article

References (36)

1. BARR, E., and LEIDEN, J.M. (1991). Systemic delivery of recombinant proteins by genetically modified myoblasts. Science 254, 1507-1509.
2. CARDOSO, M.C., LEONHARDT, H., and NADAL GINARD, B. (1993). Reversal of terminal differentiation and control of DNA replication: cyclin A and Cdk2 specifically localize at subnuclear sites of DNA replication. Cell 74, 979-992.
3. CLARK, R., PEDEN, K., PIPAS, J., NATHANS, D., and TJIAN, R. (1983). Biochemical activities of T-antigen proteins encoded by simian virus 40 A gene deletion mutants. Mol. Cell Biol. 3, 220-228.
4. DAI, Y., ROMAN, M., NAVIAUX, R.K., and VERMA, I.M. (1992). Gene therapy via primary myoblasts: Long-term expression of factor IX protein following transplantation in vivo. Proc. Nat. Acad. Sci. USA 89, 10892-10895.
5. DAVIS, H.L., DEMENEIX, B.A., QUANTIN, B., COULOMBE, J., and WHALEN, R.G. (1993a). Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle. Hum. Gene Ther. 4, 733-740.
6. DAVIS, H.L., WHALEN, R.G, and DEMENEIX, B.A. (1993b). Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression. Hum. Gene Ther. 4, 151-159.
7. DHAWAN, J., PAN, L.C., PAVLATH, G.K., TRAVIS, M.A., LANCTOT, A.M., and BLAU, H.M. (1991). Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science 254, 1509-1512.
8. DUNCKLEY, M.G., WELLS, D.J., WALSH, F.S., and DICKSON, G. (1993). Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo. Hum. Mol. Genet. 2, 717-723.
9. ENDO, T., and NADAL-GINARD, B. (1987). Three types of muscle-specific gene expression in fusion blocked rat skeletal muscle cells: Translational control in EGTA-treated cells. Cell 49, 515-526.
10. FERRY, N., DUPLESSIS, O., HOUSSIN, D., DANOS, O., and HEARD, J.M. (1991). Retroviral-mediated gene transfer into hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 88, 8377-8381.
11. FLOTTE, T.R. (1993). Prospects for virus-based gene therapy for cystic fibrosis. J. Bioenerget. Biomembr. 25, 37-42.
12. GOMEZ, F.A.M., COATS, W.S., BAQUE, S., ALAM, T., GERARD, R.D., and NEWGARD, C.B. (1992). Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism. J. Biol. Chem. 267, 25129-25134.
13. GRAHAM, F.L., and PREVIC, L. (1991). Manipulation of adenovirus vectors. In Gene Transfer and Expression Protocols. E.J. Murray, ed.) (The Humana Press, Clifton, NJ) (pp. 109-127).
14. HAMAMORI, Y., SAMAL, B., TIAN, J., and KEDES, L. (1994). Persistent erythropoiesis by myoblast transfer of erythropoietin cDNA. Hum. Gene Ther. 5, 1349-1356.
15. HAMAMORI, Y., SAMAL, B., TIAN, J., and KEDES, L. (1995). Myoblast transfer of human erythropoietin gene in a mouse model of renal failure. J. Clin. Invest. 95, 1808-1813.
16. IUJVIDIN, S., FUCHS, O., NUDEL, U., and YAFFE, D. (1990). SV40 immortalizes myogenic cells: DNA synthesis and mitosis in differentiating myotubes. Differentiation 43, 192-203.
17. JAT, P.S., NOBLE, M.D., ATALIOTIS, P., TANAKA, Y., YANNOUTSOS, N., LARSEN, L., and KIOUSSIS, D. (1991). Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse. Proc. Natl. Acad. Sci. USA 88, 5096-5100.
18. KAY, M.A., ROTHENBERG, S., LANDEN, C.N., BELLINGER, D.A., LELAND, F., TOMAN, C., FINEGOLD, M., THOMPSON, A.R., READ, M.S., BRINKHOUS, K.M., and WOO, S. (1993). In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogs. Science 262, 117-119.
19. LIEBER, A., VRANCKEN PEETERS, M.J., MEUSE, L., FAUSTO, N., PERKINS, J., and KAY, M.A. (1995). Adenovirus-mediated urokinase gene transfer induces liver regeneration and allows for efficient retrovirus transduction of hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 92, 6210-6214.
20. MILLER, D.G., ADAM, M.A., and MILLER, A.D. (1990). Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10, 4239-4242.
21. MORGAN, D.O. (1995). Principles of CDK regulation. Nature 374, 131-134.
22. MORGAN, J.E., BEAUCHAMP, J.R., PAGEL, C.N., PECKHAM, M., ATALIOTIS, P., JAT, P.S., NOBLE, M.D., FARMER, K., and PARTRIDGE, T.A. (1994). Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutation-specific cell lines. Dev. Biol. 162, 486-498.
23. NAHREINI, P., WOODY, M.J., ZHOU, S.Z., SRIVASTAVA, A., GRAHAM, F.L., and PREVEC, L. (1993). Versatile adeno-associated virus 2-based vectors for constructing recombinant virions Adenovirus-based expression vectors and recombinant vaccines. Gene 124, 257-262.
24. NALDINI, L., BLOMER, U., GALLAY, P., ORY, D., MULLIGAN, R., GAGE, F.H., VERMA, I.M., and TRONO, D. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267.
25. NIGG, E.A. (1995). Cyclin-dependent protein kinases: Key regulators of the eukaryotic cell cycle. BioEssays 17, 471-480.
26. PRICE, J., TURNER, D., and CEPKO, C. (1987). Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA 84, 156-160.
27. QUANTIN, B., PERRICAUDET, L.D., TAJBAKHSH, S., and MANDEL, J.L. (1992). Adenovirus as an expression vector in muscle cells in vivo. Proc. Natl. Acad. Sci. USA 89, 2581-2584.
28. ROE, T., REYNOLDS, T.C., YU, G., and BROWN, P.O. (1993). Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12, 2099-2108.
29. SEN, A., DUNNMON, P., HENDERSON, S.A., GERARD, R.D, and CHIEN, K.R. (1988). Terminally differentiated neonatal rat myocardial cells proliferate and maintain specific differentiated functions following expression of SV40 large T antigen. J. Biol. Chem. 263, 19132-19136.
30. SHERR, C.J. (1995). D-type cyclins. Trends Biochem. Sci. 20, 187-190.
31. STRATFORD-PERRICAUDET, L.D., MAKEH, I., PERRICAUDET, M., and BRIAND, P. (1992). Widespread long-term gene transfer to mouse skeletal muscles and heart. J. Clin. Invest. 90, 626-630.
32. SUGANO, S., and YAMAGUCHI, N. (1984). Two classes of transformation-deficient, immortalization-positive simian virus 40 mutants constructed by making three-base insertions in the T-antigen gene. J. Virol. 52, 884-891.
33. THOMASON, D.B., and BOOTH, F.W. (1990). Stable incorporation of a bacterial gene into adult rat skeletal muscle in vivo. Am. J. Physiol. 258, C578-C581.
34. WEBER BENAROUS, A., DECAUX, J.F., BENNOUN, M., ALLEMAND, I., BRIAND, P., and KAHN, A. (1993). Retroviral infection of primary hepatocytes from normal mice and mice transgenic for SV40 large T antigen. Exp. Cell Res. 205, 91-100.
35. WOLFF, J.A., LUDTKE, J.J., ACSADI, G., WILLIAMS, P., and JANI, A. (1992). Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum. Mol. Genet. 1, 363-369.
36. YAFFE, D., and SAXEL, O. (1977). A myogenic cell line with altered serum requirements for differentiation. Differentiation 7, 159-166.